Opyl delivers maiden profit as first-half revenue jumps 33%

Opyl has delivered its first-ever profit as healthcare companies begin to realise the potential of using social media for market research and clinical trial recruitment.

“Opyl is at a very exciting crossroads,” said CEO Michelle Gallaher. “The company is well-positioned to accelerate into the $US64 billion ($81.7 billion) global clinical trial services market in the coming months with a competitive recruitment offering, leveraging our deep in-house expertise in social media advertising in health and search engine optimisation.”

This is only an excerpt from an article written by Stockhead. The full version can be found here